Susquehanna International Group
AXDX

Susquehanna International Group’s Accelerate Diagnostics AXDX Stock Holding History

Susquehanna International Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,600
Closed -$33.5K – 12161
2024
Q3 		$33.5K Hold
19,600
– – ﹤0.01% 11508
2024
Q2 		$22.9K Sell
19,600
-200
-1% -$209 ﹤0.01% 11634
2024
Q1 		$19.6K Buy
+19,800
New +$31.3K ﹤0.01% 11822
2022
Q4 		– Sell
-1,280
Closed -$19K – 12375
2022
Q3 		$19K Buy
+1,280
New +$21.2K ﹤0.01% 12614
2021
Q3 		– Sell
-3,230
Closed -$260K – 12718
2021
Q2 		$260K Sell
3,230
-3,230
-50% -$257K ﹤0.01% 11070
2021
Q1 		$537K Buy
+6,460
New +$655K ﹤0.01% 9299
2020
Q4 		– Sell
-4,730
Closed -$504K – 10989
2020
Q3 		$504K Buy
4,730
+30
+0.6% +$4.17K ﹤0.01% 7658
2020
Q2 		$713K Sell
4,700
-7,450
-61% -$735K ﹤0.01% 6619
2020
Q1 		$1.01M Sell
12,150
-800
-6% -$113K ﹤0.01% 5370
2019
Q4 		$2.19M Sell
12,950
-1,450
-10% -$239K ﹤0.01% 4169
2019
Q3 		$2.67M Buy
14,400
+490
+4% +$94.7K ﹤0.01% 3696
2019
Q2 		$3.18M Sell
13,910
-36,240
-72% -$7.09M ﹤0.01% 3356
2019
Q1 		$10.5M Buy
50,150
+20,680
+70% +$3.88M ﹤0.01% 1701
2018
Q4 		$3.39M Buy
29,470
+17,370
+144% +$2.57M ﹤0.01% 2761
2018
Q3 		$2.78M Sell
12,100
-500
-4% -$111K ﹤0.01% 3477
2018
Q2 		$2.81M Sell
12,600
-730
-5% -$163K ﹤0.01% 3478
2018
Q1 		$3.05M Sell
13,330
-10,710
-45% -$2.81M ﹤0.01% 3233
2017
Q4 		$6.3M Buy
24,040
+13,110
+120% +$3.07M ﹤0.01% 2285
2017
Q3 		$2.45M Buy
10,930
+6,560
+150% +$1.61M ﹤0.01% 3541
2017
Q2 		$1.2M Buy
4,370
+230
+6% +$62.3K ﹤0.01% 4899
2017
Q1 		$1M Buy
+4,140
New +$946K ﹤0.01% 5130
2016
Q3 		– Sell
-2,550
Closed -$367K – 8371
2016
Q2 		$367K Buy
2,550
+920
+56% +$123K ﹤0.01% 6639
2016
Q1 		$234K Sell
1,630
-1,820
-53% -$257K ﹤0.01% 7696
2015
Q4 		$741K Buy
3,450
+540
+19% +$98.6K ﹤0.01% 6024
2015
Q3 		$471K Buy
2,910
+750
+35% +$162K ﹤0.01% 7240
2015
Q2 		$570K Buy
2,160
+120
+6% +$28.7K ﹤0.01% 7359
2015
Q1 		$459K Buy
2,040
+700
+52% +$146K ﹤0.01% 7246
2014
Q4 		$257K Sell
1,340
-5,820
-81% -$1.25M ﹤0.01% 8387
2014
Q3 		$1.54M Sell
7,160
-2,460
-26% -$478K ﹤0.01% 5099
2014
Q2 		$2.5M Buy
9,620
+1,300
+16% +$284K ﹤0.01% 4221
2014
Q1 		$1.81M Buy
8,320
+6,890
+482% +$1.02M ﹤0.01% 4503
2013
Q4 		$174K Buy
+1,430
New +$191K ﹤0.01% 8369

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Susquehanna International Group's AXDX Position: Q2 2025 in Review

Susquehanna International Group sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 55,268 shares — an estimated $38.7K sold.

Susquehanna International Group first reported a position in AXDX in Q4 2013 and held it in 37 quarters. The position peaked at $10.8M in Q3 2018. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • Susquehanna International Group reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 55,268 Accelerate Diagnostics shares in Q2 2025, an estimated $38.7K.
  • Susquehanna International Group first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 37 quarters.
  • Susquehanna International Group's Accelerate Diagnostics position peaked at $10.8M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.